QUÉBEC CITY, Sept. 26, 2012 /PRNewswire/ - Aeterna Zentaris Inc.
(NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that its
Senior Vice President and CFO, Dennis Turpin, CPA CA, will be
presenting a corporate overview at BioContact on Wednesday, October 3,
2012, at 2 pm (Eastern), in the Grande-Allée Room of the Château
Laurier Hotel in Québec City, Canada.
About Aeterna Zentaris
Aeterna Zentaris is an oncology and endocrinology drug development
company currently investigating treatments for various unmet medical
needs. The Company's pipeline encompasses compounds at all stages of
development, from drug discovery through to marketed products. For more
information please visit www.aezsinc.com.
SOURCE AETERNA ZENTARIS INC.